Literature DB >> 4035286

Crohn's disease. Clinical manifestations.

E Lind, O Fausa, K Elgjo, E Gjone.   

Abstract

Two hundred and fourteen patients with Crohn's disease (CD) consecutively admitted during a 5-year period were observed for a mean of 9 years (range, 0-35 years). Sixty-five per cent had their initial symptoms between 10 and 30 years of age and 9.2% after the age of 50 years. The CD diagnosis was delayed for more than 10 years in 8% (mean, 4.5; range, 0-31 years). Large-bowel involvement was seen in 82.5% and was the only localization of the disease in a fourth of the patients. Recurrent abdominal pain occurred in two-thirds of patients with ileal or ileocolic disease. Acute abdominal pain was the cause of laparotomy in 14% of the patients with ileocolic CD. Diarrhea and rectal bleeding occurred significantly more often in colonic CD, whereas fistula complicated ileocolic disease more often than isolated involvement of small or large bowel. Associated extraintestinal diseases were seen in 117 patients (55%), most frequently related to colonic involvement (joint disease, 21%; eye, 12%, skin, 8%). Of 26 patients (12%) with liver pathology, 10 patients had amyloid deposits. Amyloidosis was diagnosed in altogether 12 patients (6%).

Entities:  

Mesh:

Year:  1985        PMID: 4035286     DOI: 10.3109/00365528509089192

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

1.  Amyloidosis of the gallbladder mimicking gallbladder cancer.

Authors:  A-Hon Kwon; Katsushige Tsuji; Hitoshi Yamada; Kazuichi Okazaki; Noriko Sakaida
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

2.  Serum Cytokine Profiles in Children with Crohn's Disease.

Authors:  Ekaterina Vasilyeva; Sayar Abdulkhakov; Georgi Cherepnev; Ekaterina Martynova; Irina Mayanskaya; Alina Valeeva; Rustam Abdulkhakov; Dilyara Safina; Svetlana Khaiboullina; Albert Rizvanov
Journal:  Mediators Inflamm       Date:  2016-12-13       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.